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Introduction. Oral squamous cell carcinoma (OSCC) is a malignant tumor with 640,000 new cases 
annually in the world [1]. Saliva testing is non-invasive procedure that is capable to detect potential 
biomarkers for OSCC. It was shown that elevated level of p53 protein was identified in OSCC patients 
at different stages of the disease (ibid). Camelid antibodies containing only variable regions, nanobodies 
(VHH) and single-chain variable regions (scFv) with VH and VL, are becoming popular in many 
biological studies including diagnostic applications. It was identified that VL region alone showed higher 
affinity to p53 than VHH, and dimerization of VL region with another one increases the affinity up 
to 10 folds [2]. Camelid antibodies have similar affinity to its substrate as human antibodies and can 
be conjugated to other proteins without functional lose. They can be expressed and secreted in many 
organisms including E.Coli in high amount, which reduces the cost of antibodies production. Thus, the 
aim of this project is to design a biosensor, based on available sequence of antibodies, to detect p53 in 
saliva samples for OSCC diagnosis. 
Materials and methods. We transformed E. coli Dh5 alpha with pVDL9.3 vector encoding HlyB and 
HlyD genes and then with with pUC57 vector encoding Vhhp53 gene conjugated to leucine zipper, red 
fluorescent protein and alpha-hemolysin (HlyA). Then we induced the expression of the protein with 
1uM IPTG and collected both lysate of the cells and the medium to check the photometric intensity of 
protein expression with spectrophotometer. We purified proteins with Ni/NTA columns and checked 
the size on SDS PAGE gel. Furthermore we mausered the concentration of the purified proteins with 
nanodrop ND8000. 
Results and discussion. We obtained a single band of the expected size 71 kDa which accounts for 
the size of single chain Vhhp53 antibody. We did not observe the band for dimerized protein, but we are 
planning to check whether the dimerization occurs or not on native SDS PAGE in the future. 
Conclusions. Vhp53 nanobody was purified from both medium and bacterial lysate. We plan to test 
the affinity of this nanobody for cancer biomarker p53. In future, this protein-nanobody interaction can 
be used to design a biosensor, based on available sequence of antibodies, in particular, to detect p53 in 
saliva samples for OSCC diagnosis 
Acknowledgments. We thank Dr. Damira Kanayeva, Dr. Kenneth Alibek, Dr. Gonzalo Hortelano, Dr. 
Tim Shipley, Dr. Luiz Angel, Dr. Rebecca Bocanegra, Dr. Ana Cuervo, Dr. Alexander Shustov,; Sholpan 
Kauanova, Nurgul Imangali, and Madina Shaimerdenova for their support and collaboration. 
References. 
1. Shah FD, Begum R, Vajaria BN, Patel KR, Patel JB, Shukla SN, Patel PS. (2011). A review 
on salivary genomics and proteomics biomarkers in oral cancer. Indian Journal of Clinical 
Biochemistry. 26(4):326-334. DOI 10.1007/s12291-011-0149-8 
2. Smolarek, D., Bertrand, O., & Czerwinski, M. (2012). Variable fragments of heavy chain 
antibodies (VHHs): a new magic bullet molecule of medicine?. Advances in Hygiene & 
Experimental Medicine/Postepy Higieny i Medycyny Doswiadczalnej, 66. 
54 
